immuno oncology frontiers world miami


Louis Juliano

Louis Juliano

Senior Vice President, Global Sales & Business Development, HemaCare Corporation

Louis Juliano has been a Senior Vice President with HemaCare since joining the company in July 2011.  He helped create HemaCare’s current strategic focus and direction.  He was instrumental in HemaCare’s transition from traditional infusible blood products to its current bioresearch and cell therapy products and services focus.  In his current role, Mr. Juliano heads up HemaCare's global sales and business development within the bioresearch product and cell therapy lines of business.  He leads the company’s sales team and has established its global distribution network.  He also provides executive leadership support throughout the company. 

Mr. Juliano is a seasoned executive with over 25 years of leadership experience within healthcare service companies such as Cardinal Health and Walgreens Infusion and Respiratory Services.  He brings strong operations, sales, Lean Six Sigma, and general management skills to the HemaCare leadership team.

Mr. Juliano received his Bachelor of Science degree in Pharmacy from Purdue University in 1984.  Mr. Juliano completed a Cardinal Health sponsored executive MBA program affiliated with Pepperdine University in 1996.  He is a licensed pharmacist and nuclear pharmacist in New York and Florida. 

  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy